Research and Markets (http://www.researchandmarkets.com/research/qx89q2/chemotherapy) has announced the addition of the "Chemotherapy Induced Neutropenia-Pipeline Insights, 2014" subscription to their offering.

This Chemotherapy Induced Neutropenia-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Chemotherapy Induced Neutropenia.

This report provides information on the therapeutic development based on the Chemotherapy Induced Neutropenia dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:

  1. Chemotherapy Induced Neutropenia Overview
  2. Chemotherapy Induced Neutropenia Pipeline Therapeutics
  3. Chemotherapy Induced Neutropenia Therapeutics under Development by Companies
  4. Chemotherapy Induced Neutropenia Late Stage Products (Filed and Phase III)
  5. Comparative Analysis
  6. Chemotherapy Induced Neutropenia Mid Clinical Stage Products (Phase II)
  7. Comparative Analysis
  8. Chemotherapy Induced Neutropenia Early Clinical Stage Products (Phase I and IND Filed)
  9. Comparative Analysis
  10. Chemotherapy Induced Neutropenia Discovery and Pre-Clinical Stage Products
  11. Comparative Analysis
  12. Drug Candidate Profiles
  13. Chemotherapy Induced Neutropenia - Therapeutics Assessment
  14. Assessment by Monotherapy Products
  15. Assessment by Combination Products
  16. Assessment by Route of Administration
  17. Assessment by Molecule Type
  18. Chemotherapy Induced Neutropenia - Discontinued Products
  19. Chemotherapy Induced Neutropenia - Dormant Products
  20. Companies Involved in Therapeutics Development for Chemotherapy Induced Neutropenia
  21. Appendix

For more information visit http://www.researchandmarkets.com/research/qx89q2/chemotherapy